STAAR Surgical Shares Drop Despite Better-Than-Expected Preliminary Q2 Sales

Despite reporting stronger-than-anticipated preliminary second-quarter sales figures for 2026, STAAR Surgical (STAA) experienced a significant decline in its stock price on Friday. Analysts expressed concerns about the company's long-term outlook, contributing to a potential worst one-day drop since February 2025.

By Dulan Lokuwithana, SA News Editor · Seeking Alpha · July 17, 2026, 18:32 UTC

STAAR Surgical Shares Drop Despite Better-Than-Expected Preliminary Q2 Sales

Tickers: $STAA

Topics: analyst concerns MedTech Q2 sales figures

Read the full article at Seeking Alpha

More World news

Donald Trump Suggests Tim Cook as Potential Successor for Nvidia Following Jensen Huang's Resignation The Verge · November 12, 2026, 16:09 UTC
Yankees President Randy Levine Advocates for Protect College Sports Act and Addresses MLB Labor Uncertainty CNBC · November 12, 2026, 15:34 UTC
Donald Trump Suggests Apple Chairman Tim Cook as Potential Successor to Nvidia CEO Jensen Huang TechCrunch · November 12, 2026, 16:12 UTC
Bybit Announces Title Partnership for Inaugural Stockholm Open ATP 250 Tournament PR Newswire · November 12, 2026, 16:11 UTC
SES AI Reports Q3 2026 Revenue Growth Amid Strategic Shift Toward Drone Battery Market Motley Fool · November 12, 2026, 16:10 UTC
Nvidia Shares Decline Following Resignation of CEO Jensen Huang Seeking Alpha · November 12, 2026, 16:07 UTC
Broadcom and Micron Identified as Top Alternatives to Nvidia Amid Leadership Uncertainty Motley Fool · November 12, 2026, 16:03 UTC
Thomson Reuters Executives to Present at TD Securities Technology Conference PR Newswire · November 12, 2026, 16:00 UTC
BHP to Restructure Australian Iron Ore Operations Amid Rising Costs Seeking Alpha · November 12, 2026, 15:59 UTC
Capri Investment Group and GRIT Chicago Unveil $10 Billion Bronzeville Lakefront Development Plan PR Newswire · November 12, 2026, 16:00 UTC